Vesalio Announces Clinical Study Initiative for the Recently Launched pVasc Thrombectomy System and Planned Attendance at TCT, VIVA, and VEITH Meetings
VesalioVesalio, a global thrombectomy company dedicated to advancing patient care across all vascular diseases, announces the initiation of a prospective, single-arm, multi-center study supporting the recently launched pVasc鈩 Thrombectomy System for non-surgically removing peripheral occlusions.